文献速递糖尿病肥胖与代谢综合征性腺与生殖内分泌

妊娠期糖尿病与中老年女性生物学衰老加速相关

Gestational Diabetes Mellitus and Accelerated Biological Aging in Middle-Aged and Elderly Women.
PubMed 文献 · Diabetes Care · 2026-01-01

基于英国生物银行178,363名经产女性的数据,既往妊娠期糖尿病(GDM)史与表型年龄加速增加2.34年(95%CI 2.02-2.66)相关,且该关联独立于2型糖尿病及共病发生。表型年龄加速部分介导了GDM与全因死亡、2型糖尿病和心血管疾病的正向关联。

要点

  • 有GDM史的女性生物学年龄比无GDM者平均老2.34年(95%CI 2.02-2.66)。
  • GDM相关衰老加速在体力活动少和肥胖女性中更显著(交互P<0.01)。
  • 表型年龄加速分别解释GDM与全因死亡、2型糖尿病、心血管病关联的57.0%、12.4%、21.9%。

核心结论

  • 有GDM史的女性生物学年龄较无GDM者更大。
  • 生物学衰老加速部分解释了GDM与不良健康结局之间的关联。

研究设计与样本

  • 研究纳入英国生物银行中178,363名经产女性,基线调查收集GDM史并检测生物学衰老生物标志物。
  • GDM史通过触摸屏问卷和医院入院记录链接获取。
  • 生物学衰老采用基于实际年龄和九项基线生物标志物的表型年龄(PhenoAge)评估,衰老加速为PhenoAge对实际年龄回归的残差。
  • 随访期间评估全因死亡和心血管代谢疾病发生。

主要发现

  • 178,363名女性平均年龄57.0岁(SD 7.9),其中1,141人有GDM史。
  • 多变量调整模型中,GDM史与表型年龄加速增加2.34年(95%CI 2.02-2.66)相关。
  • 该关联在GDM后发生2型糖尿病及相关共病与否均持续存在。
  • 亚组结果一致,但GDM相关表型年龄加速在体力活动较少和肥胖女性中更显著(交互P均<0.01)。
  • 中介分析显示表型年龄加速解释GDM与全因死亡、2型糖尿病、心血管疾病正向关联的比例分别为57.0%(95%CI 21.0-86.9)、12.4%(95%CI 7.3-20.4)、21.9%(95%CI 14.0-32.5)。

临床怎么用

  • 对有GDM史的中老年女性,可考虑将生物学衰老加速纳入风险评估。
  • 对体力活动少或肥胖的GDM史女性,可能需更关注衰老相关健康结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the association between gestational diabetes mellitus (GDM) and accelerated biological aging in middle-aged and elderly women. RESEARCH DESIGN AND METHODS: We included parous women with a baseline survey on history of GDM and biological aging biomarkers from the UK Biobank. Information regarding prior GDM was collected via a touchscreen questionnaire and linkage to hospital admission records. Biological aging was evaluated using validated phenotypic age (PhenoAge) based on chronological age and nine biomarkers measured at baseline (2006-2010). Biological aging acceleration was determined as the residual by regressing PhenoAge estimates on chronological age. All-cause mortality and incident cardiometabolic disease during follow-up were also assessed. RESULTS: Among the 178,363 women (mean age, 57.0 [SD 7.9] years), 1,141 had a history of GDM. In a multivariable-adjusted model, a history of GDM was associated with an increase in PhenoAge acceleration by 2.34 (95% CI 2.02, 2.66) years. The association persisted regardless of the occurrence of type 2 diabetes and related comorbidities after GDM. Consistent results were observed across subgroups, while the GDM-related PhenoAge acceleration was more prominent among women with less physical activity and obesity (both Pinteraction < 0.01). The mediation analysis demonstrated that PhenoAge acceleration explained 57.0% (95% CI 21.0, 86.9), 12.4% (7.3, 20.4), and 21.9% (14.0, 32.5) of the positive associations between GDM and all-cause mortality, type 2 diabetes, and cardiovascular disease, respectively. CONCLUSIONS: Women with a history of GDM were biologically older than their non-GDM counterparts. The biological aging acceleration partially accounted for the associations between GDM and adverse health outcomes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Wang B, Wang N, Yin X, et al. Gestational Diabetes Mellitus and Accelerated Biological Aging in Middle-Aged and Elderly Women. Diabetes Care. 2026. PMID: 41401076. doi:10.2337/dc25-1842

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。